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Abstract
Background: Low income individuals with diabetes are at particularly high risk for poor health
outcomes. While specialized diabetes care may help reduce this risk, it is not currently known
whether there are significant clinical differences across income groups at the time of referral. The
objective of this study is to determine if the clinical profiles and medication use of patients referred
for diabetes care differ across income quintiles.
Methods: This cross-sectional study was conducted using a Canadian, urban, Diabetes Education
Centre (DEC) database. Clinical information on the 4687 patients referred to the DEC from May
2000 – January 2002 was examined. These data were merged with 2001 Canadian census data on
income. Potential differences in continuous clinical parameters across income quintiles were
examined using regression models. Differences in medication use were examined using Chi square
analyses.
Results: Multivariate regression analysis indicated that income was negatively associated with BMI
(p < 0.0005) and age (p = 0.023) at time of referral. The highest income quintiles were found to
have lower serum triglycerides (p = 0.011) and higher HDL-c (p = 0.008) at time of referral. No
significant differences were found in HBA1C, LDL-c or duration of diabetes. The Chi square
analysis of medication use revealed that despite no significant differences in HBA1C, the lowest
income quintiles used more metformin (p = 0.001) and sulfonylureas (p < 0.0005) than the wealthy.
Use of other therapies were similar across income groups, including lipid lowering medications.
High income patients were more likely to be treated with diet alone (p < 0.0005).
Conclusion: Our findings demonstrate that low income patients present to diabetes clinic older,
heavier and with a more atherogenic lipid profile than do high income patients. Overall medication
use was higher among the lower income group suggesting that differences in clinical profiles are not
the result of under-treatment, thus invoking lifestyle factors as potential contributors to these
findings.
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Background
Individuals with low income are at increased risk for the
development of diabetes [1-3] Low income is also an
independent predictor of hospitalization for the acute
complications of diabetes and is associated with higher
odds of microvasculopathy and heart disease [4-6].
There is an extensive literature that explores the associa-
tion between income and health outcomes among the
general population. The relationship between income and
health outcomes is complex and is mediated by a number
of factors. Potential mediating factors include differential
access to care [7-10], behavioural and psycho-social fac-
tors [11-16], and biologic factors [17-19]. Several
researchers have shown, that even within universal health
care systems, the poor are less effective at accessing spe-
cialty care [7-10,20]. They are also more likely to partake
in poor health-related behaviours (such as smoking, con-
suming diets low in fruits and vegetables, and sedentary
lifestyles [20-23]) and are more likely to be overweight or
obese [22,24,25]. Biologic differences among income
groups have also been identified. High income groups are
more likely to have higher levels of HDL cholesterol and
low income groups have been found to have subtle
changes in their neuro-endocrine and immune responses
that may predispose them to atherosclerosis [17-19,26].
Low income patients with diabetes are at greater risk for
adverse health outcomes but the factors influencing this
relationship are unclear. There is emerging evidence that
income does not appear to effect access to specialty diabe-
tes care [27,28], but little is known about clinical, behav-
ioural or biologic differences across income groups,
among those with diabetes.
In recognizing our incomplete understanding of the
income relationship to diabetes, this study proposed to
explore whether there are clinical and/or biologic differ-
ences across income groupings among patients referred to
an urban diabetes education centre (DEC). The study's
objectives specifically included an assessment of the clin-
ical profiles (including medication use) of patients across




To conduct this work, we used a regional DEC database
that captures basic demographic information on all
attendees to the regional clinic situated in Calgary,
Alberta, a large Canadian city. The sampling frame was all
active patients at the DEC from May 1, 2000 to January 9,
2002. The sample consisted of 4687 patients. All patients
included were from a single health region within the prov-
ince of Alberta. This DEC is the single regional provider of
diabetes education services. Access is dependent upon
physician referral to the centre. The postal codes of
patients registered in the DEC database were linked to
their corresponding dissemination area (DA) using the
Statistics Canada Postal Code Conversion File (PCCF).
Neighborhood income data were obtained from Statistics
Canada Census data (2001). We defined a neighborhood
as equivalent to a census dissemination area (DA)- a small
geographic area covered by a single census data collector
which typically contains 400–700 persons. Therefore,
median household income per DA was the income meas-
ure used in this study. These data were merged with the
DEC database on the variable DA. Neighbourhood
income has been shown to be reasonably concordant with
individual income in urban settings [29,30]. There is also
increasing evidence that neighbourhood income is valid
SES construct that predicts health outcomes independ-
ently of individual income [31,32].
Derivation of Income Quintiles
Household income quintiles were generated from DA
annual income data. All income data is reported in Cana-
dian dollars. The size and associated incomes for the
income quintiles were as follows:
1) Income quintile 1, n = 940, less than $40877
2) Income quintile 2, n = 937, $40878 – $53065
3) Income quintile 3, n = 936, $53066 – $62921
4) Income quintile 4, n = 938, $62922 – 79828
5) Income quintile 5, (n = 936), more than $79829
Study Variables and Statistical Analyses
Physicians referring patients to the DEC complete a stand-
ardized referral form that includes clinical data. This
information was then entered into the DEC patient regis-
try. Clinical information examined in this study included:
serum hemoglobin A1C (HBA1C); serum lipid profiles
including levels of low density lipoprotein (LDL-c), high
density lipoprotein (HDL-c) and triglyceride; microalbu-
min to creatinine ratios and medications used at time of
referral. Height and weight are measured upon presenta-
tion to clinic; these measures were used to calculate the
body mass index (BMI) which was then entered into the
DEC database.
Potential differences in continuous clinical parameters
across income quintiles were examined using regression
models. If inspection of the distribution of these variables
suggested a linear relationship between income and the
variable of interest, then income quintile was modeled asCardiovascular Diabetology 2007, 6:11 http://www.cardiab.com/content/6/1/11
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a single ordinally-coded predictor variable. If, on the
other hand, the relationship was not linear, then regres-
sion was performed using dummy variables for each
income quintile relative to the lowest income quintile as
a reference group. Covariates considered in these models
included sex and medication use. Differences in categori-
cally-coded medication use across income quintiles,
meanwhile, were examined using Chi square analyses. All
statistical analyses were performed in STATA, version 8.
Results
Descriptive Analysis
Clinical characteristics of patients referred for diabetes
care and education are listed, by income quintile, in Table
1. The median age of patients increased as income level
decreased. The median age in the highest income groups
(quintile 5) was 55.3 years compared to the lowest
income group (quintile 1) which was almost 2 years older
at time of referral with a median age of 57.0 years. There
was a similar inverse relationship between income level
and BMI. The median BMI in the wealthiest quintile
(quintile 5) was 28 compared median BMIs of 29.6 in
quintile 1 and 29.8 in quintile 2. Our results also indicate
that the lowest income quintile presents to clinic later
from the time of diagnosis of diabetes. The median dura-
tion of diabetes was 4 years in the lowest quintile, com-
pared to 3 years in all of the other quintiles. In terms of
diabetes-related clinical parameters, patients did not dif-
fer significantly across groups with respect to serum LDL-
c levels. Patients in the highest income quintile had the
highest HDL-c. An inverse relationship between income
and triglycerides is suggested as the median triglyceride
levels range from 2.40 mmol/L in the lowest income
group down to 2.12 mmol/L in the highest income group.
Glycemic control appears to be slightly better in the high-
est income group as evidenced by a median HBA1C of
8.4% in quintile 5 compared to a median HBA1C of 8.9%
in all other income groups. There is also a suggestion of a
negative association between microalbumin creatinine
ratio (M:C) and income. The lowest income group had a
median M:C of 2.3 compared to a median M:C of 1.5 in
the highest income group. Boxplots illustrating the distri-
bution of clinical characteristics are illustrated in figure 1.
Regression Analysis
Clinical profiles
Visual inspection of the distribution of the variables age,
body mass index (BMI), and duration of diabetes (Figure
1, panels a, b and c), suggested a linear relationship
between those clinical characteristics and income. Linear
regression on ordinally coded income groupings was thus
performed (see Table 2) and indeed demonstrated a sig-
nificant negative association between age at the time of
referral and median household income per DA (β-coeffi-
cient = -.339, 95% CI -0.65 – -0.03). A similar negative
association was noted between BMI and income where
the β-coefficient was found to be -.362 (95% CI -0.51 – -
0.21). This relationship remained significant even after
controlling for age and diabetes medication use. These
findings reveal that wealthy patients presenting for diabe-
tes education are younger and leaner than those from
lower income groups. While this might suggest that the
wealthy are presenting earlier in the course of their diabe-
tes, we found no significant association between income
and the duration of diabetes (β-coefficient=-.0167, 95%
CI -1.32 – 1.29).
Visual inspection of the distribution on the clinical varia-
bles of LDL-c, HDL-c, triglycerides, HBA1C and micro-
albumin:creatinine ratio did not reveal an obvious linear
relationship in the associations with income (Figure 1,
panels d-h). In this instance, regression modeling was
done by comparing each individual income quintile to a
pre-defined reference group, income quintile 1. Table 3
lists the results of the analysis. No significant association
was found between income and level of glycemic control
as measured by HBA1C. After controlling for age, sex, and
differences in the use of anti-diabetic medications, the
highest income quintile had a trend towards a lower
HBA1C. Similarly, while no significant association was
found with respect to microalbumin:creatinine ratio, the
box plot of this variable (Figure 1, panel h) suggests that
the highest income groups have lower ratios.
The association of serum lipid levels at the time of referral
was also examined. While no relationship was found
between the levels of LDL-c and income quintile, signifi-
cant findings were noted with respect to HDL-c and trig-
lyceride levels. In the unadjusted analysis, HDL-c was
highest in the wealthiest income quintile but this did not
reach statistical significance. After adjusting for differences
in sex, age and use of lipid lowering medications, the asso-
ciation strengthened and became significant. Triglyceride
levels were similarly lowest in the highest income group,
and this was significant both in the unadjusted and
adjusted analyses (Table 3).
Medication Use
The proportions of patients, by income quintile, pre-
scribed specific medications are presented in Table 4. Chi
square analyses indicate socio-economic gradients for the
use of certain diabetes therapies. A statistically significant
gradient was noted for the use of diet alone to manage dia-
betes. In the lowest income quintile, 14.4% of patients
presented on diet alone, compared to 24.4% in the high-
est income group (χ2 = 44.22, p < 0.0005). An inverse gra-
dient was noted in the use of oral diabetes medications.
Metformin was used by 37.3% of patients in the lowest
income group, compared to 30% in the highest income
group (χ2 = 18.85, p = 0.001). Sulfonylureas were alsoCardiovascular Diabetology 2007, 6:11 http://www.cardiab.com/content/6/1/11
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more commonly used in the lower income quintiles com-
pared to the highest income quintiles (χ2 = 25.63, p <
0.0005). No significant differences were found across
income quintiles in the use of glucosidase inhibitors (χ2 =
2.99, p = 0.558), thiazolideindiones (TZD) (χ2 = 2.93, p =
0.087) or subcutaneous insulin (χ2 = 2.56, p = 0.392).
Discussion
Individuals with low income and diabetes are at increased
risk for developing vascular complications. While the
processes mediating this low income/poor health out-
come relationship have been examined in the general
population, little is known about the factors mediating
this relationship among those with diabetes. Previous
research has shown that access to specialty diabetes care
appears equitable across income groups [27,28], suggest-
ing that differences in health outcomes may be mediated
by other factors.
Clinical and Biologic Factors
This study demonstrates that there are clinically signifi-
cant differences in some biologic parameters across
income quintiles and that low income patients present to
clinic with higher risk profiles. Low-income patients are
older at time of referral and have more atherogenic meta-
bolic profiles with higher serum triglycerides and lower
HDL levels, which are associated with a higher risk for
developing cardiovascular disease [33-35]. While a signif-
icant association between income and HBA1C was not
noted, inspection of the distribution of HBA1C suggests a
trend towards a lower HBA1C in the highest income quin-
tile.
This study also suggests that differences in metabolic sta-
tus are not due to overt under-treatment of the economi-
cally disadvantaged. The lowest income groups were using
more sulfonylureas and metformin compared to the
wealthiest groups. Even the use of more costly therapies
such as TZD and lipid-lowering therapies were similar
across income groups.
Behavioural Factors
This study also provides some insight into potential
health related behavioural differences across income
groups. It has been shown in previous research that seden-
tary lifestyles are more common among lower income
populations. In this study, the lower income groups had
the highest BMIs. This raises the possibility that the lower
income groups are less physically active than their wealthy
counterparts. The lower HDL levels and higher triglycer-
ides might also reflect behavioural differences with
respect to diet and/or exercise [36]. Unfortunately, the
data set used in this study does not contain detailed data
on diet or exercise so we were unable to explicitly assess
differences in these important behaviours.
Other considerations
High income is frequently associated with higher health
literacy and a greater ability to apply health-related
knowledge [37,38]. It should be noted that while we did
not find that HBA1Cs differ significantly at the time of
referral, others have documented that individuals from
higher socio-economic strata are more likely to experience
significant lowering of their HBA1Cs after assessment at
diabetes clinic [37,38]. It would be most interesting to
know had the clinical profiles of these patients been re-
evaluated 1 year following their referral whether the dif-
ferences noted would have remained the same, been
attenuated or perhaps been even more pronounced due to
differences in health literacy.
Table 1: Clinical Profiles at time of referral by income quintile
Income Quintile
1 (low) 2 3 4 5 (high) p-for trend*
Clinical Characteristic Median (IQR)
Age (in years) 56.95 (22.9) 56.52 (21.48) 56.95 (19.94) 55.24 (19.44) 55.27 (18.5) 0.032
BMI 29.6 (8.6) 29.8 (8.3) 29 (7.9) 29.5 (8.2) 28 (7.2) <0.0005
Duration of Diabetes (in years) 4 (9) 3 (8) 3 (10) 3 (9) 3 (7) 0.98
LDL-c (mmol/L) 3.01 (1.26) 2.97 (1.1) 3.02 (1.22) 2.97 (1.23) 2.99 (1.26) **
HDL-c (mmol/L) 1.12 (0.41) 1.1 (0.36) 1.09 (0.37) 1.1 (0.36) 1.15 (0.35) **
Triglycerides (mmol/L) 2.40 (1.88) 2.29 (1.99) 2.41 (2.0) 2.32 (1.76) 2.12 (1.61) **
HBA1C (%) 8.9 (3.7) 8.9 (3.7) 8.9 (3.5) 8.9 (3.7) 8.4 (3.3) **
Microalbumin: Creatinine 2.3 (9) 1.95 (7.7) 2.4 (7.1) 1.6 (5.9) 1.5 (5) **
*results of univariate analyses for trend when income could be modeled as a single, ordinally-coded variable
**these variables did not have a simple linear relationship with income (results of regression models where income quintiles are modeled as dummy 
variables are displayed in Table 3).Cardiovascular Diabetology 2007, 6:11 http://www.cardiab.com/content/6/1/11
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While we did not find a significant difference with respect
to the duration of the diagnosis of diabetes at the time of
referral, examination of the distribution of this variable
certainly suggests that this may, in part, be mediating
some of clinical differences noted. The wealthiest patient
group was also younger, and more likely to be controlled
with diet alone, suggesting that these patients may be pre-
senting at an earlier point in the natural history of their
diabetes. If wealthy patients were being referred earlier
(perhaps due to earlier diagnosis), this may also help
explain the inverse relationship between income and
complication risk. As there is now clear evidence that
aggressive management of blood glucose, high blood
pressure and high serum lipids will effectively prevent the
micro- and macrovascular complications of diabetes [39-
Table 2: Association of Income Quintile with General Clinical Parameters
Clinical Characteristic Co-variate B-coefficient (p-value) B-coefficient – adjusted for sex 
(p-value)
B-coefficient – adjusted for sex, 
age & therapy (p-value)
Age Quintile -.339 (0.032) -.361 (0.023)
BMI Quintile -.362 (<0.0005) -.319 (<0.0005) -.306 (<0.0005)
Duration of DM Quintile -.0167 (0.980) .0272 (0.968)
Distribution of clinical variables across income quintiles Figure 1
Distribution of clinical variables across income quintiles.
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43], it follows that the earlier a specialist intervenes, the
more effective these prevention strategies might be.
This study has limitations. This is a cross sectional study
that examined the clinical profiles of patients at one point
in time. These referrals were not necessarily index referral,
and had we compared clinical profiles at first contact with
specialty care, it is possible that some of the clinical differ-
ences noted may have been attenuated. It is noteworthy
that clinical data were entered into the DEC database from
a standardized clinic referral form. All clinical data exam-
ined in this study, therefore, were provided by the refer-
ring physician. If doctors differ in the manner in which
they complete, or do not complete this form, an informa-
Table 3: Association of Income Quintile with Diabetes-related Clinical Parameters
Clinical Parameter Income Quintile B-coefficient – Unadjusted (p-value) B-coefficient – Adjusted (p-value)*
HDL-C 1 (reference)
2 .0126 (0.798) .015 (0.76)
3 .0625 (0.201) .063 (0.20)
4 .0151 (0.757) .021 (0.67)
5 .0756 (0.120) .084 (0.09)
LDL-c 1 (reference)
2 -.0813 (0.222) -.086 (0.193)
3 -.010 (0.885) -.016 (0.805)
4 -.0391 (0.540) -.044 (0.488)
5 -.022 (0.731) -.025 (0.691)
HDL-c 1 (reference)
2 -.013 (0.52) -.01 (0.6)
3 -.018 (0.35) -.009 (0.64)
4 -.014 (0.46) -.001 (0.95)
5 .031 (0.11) .05 (0.008)
Triglycerides 1 (reference)
2 -.23 (0.40) -.22 (0.43)
3 -.05 (0.86) -.06 (0.84)
4 -.26 (0.34) -.28 (0.31)
5 -.63 (0.019) -.68 (0.011)
Microalbumin: Creatinine 1 (reference)
2 -8.56 0.058 -8.97 (0.047)
3 -2.88 0.540 -2.43 (0.602)
4 -7.58 0.097 -7.16 (0.116)
5 -6.99 0.122 -7.01 (0.119)
*Adjusted for age, sex, and therapy (HBA1C was adjusted for anti-hyperglycemic medication use, LDL-c, HDL-c and Triglycerides were adjusted for 
lipid-lowering therapy use and Microalbumin: creatinine was adjusted for anti-hypertensive medication use.)
Table 4: Association of Income with Medical Therapy Use
Income Quintile P-value
1 (low) 2 3 4 5 (high)
Therapy
Diet Only 14.1% 14.4% 16.9% 18.8% 24.4% <0.0005
Metformin 37.3% 36.1% 37.0% 31.5% 30.0% 0.001
Sulfonylureas 29.6% 30.1% 29.3% 24.1% 22.4% <0.0005
Glucosidase 
Inhibitors
2.0% 1.3% 1.8% 2.0% 1.2% 0.558
TZD 3.9% 3.5% 4.1% 4.2% 3.5% 0.886
Insulin 19.8% 18.2% 18.3% 18.6% 17.2% 0.688
Lipid Lowering 
Medication
11.8% 9.0% 9.3% 9.6% 11.0% 0.212
Anti-Hypertensive 
Medication
19.7% 21.7% 19.0% 19.7% 19.0% 0.596Cardiovascular Diabetology 2007, 6:11 http://www.cardiab.com/content/6/1/11
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tion bias could be introduced to this study. We do not
have any evidence, however, that physicians' documenta-
tion skills should differ based on the neighbourhood
income of their patients, and would assert that informa-
tion bias relating to income is unlikely.
Conclusion
This study provides important information on how the
clinical profiles of patients with diabetes differ based on
income. Given that elevated serum lipids, HBA1C and
microalbumin to creatinine ratios are all significant pre-
dictors of atherosclerosis and mortality [43-45], it is quite
plausible that these clinical differences mediate the rela-
tionship between income and health outcomes in this
population. Whether these differences are influenced by
patient, physician, or other factors, remains unclear. How-
ever, this study does provide reassurance that within Can-
ada's single payer health care system, prescribing practices
do not appear to discriminate against individuals of lower
income. In fact, overall mediation use was higher in the
lower income groups, appropriately reflecting their higher
burden of vascular risk factors.
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